Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study
Clinical trial NCT02472080 · TERMINATED
Trial details
- NCT number
- NCT02472080
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-07
- Primary completion
- 2018-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.